U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: U.S. Agent Voluntary Identification System (VIS) for Food Facility Registration
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: U.S. Agent Voluntary Identification System (VIS) for Food Facility Registration October 2020

Download the Final Guidance Document
Final Level 2 Guidance
Docket Number:
FDA-2012-D-1002
Issued by:
Guidance Issuing Office
Human Foods Program

The purpose of this guidance document is to announce that FDA has established a U.S. Agent Voluntary Identification System (VIS) in conjunction with our food facility registration database, the Food Facility Registration Module (FFRM). The purpose of the VIS is to ensure the accuracy of U.S. agent information and enable U.S. agents to independently identify the facility or facilities for which the agent has agreed to serve. This guidance provides information for U.S. agents and foreign facilities importing food into the U.S. who choose to utilize the VIS. 

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.  The use of the word should in FDA guidances means that something is suggested or recommended, but not required.

Download the Guidance

Related Information

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2012-D-1002.

Back to Top